Amyloid oligomers: A joint experimental/computational perspective on Alzheimer's disease, Parkinson's disease, type II diabetes, and amyotrophic lateral sclerosis

PH Nguyen, A Ramamoorthy, BR Sahoo… - Chemical …, 2021 - ACS Publications
Protein misfolding and aggregation is observed in many amyloidogenic diseases affecting
either the central nervous system or a variety of peripheral tissues. Structural and dynamic …

Liquid-liquid phase separation of α-synuclein: a new mechanistic insight for α-synuclein aggregation associated with Parkinson's disease pathogenesis

S Mukherjee, A Sakunthala, L Gadhe… - Journal of molecular …, 2023 - Elsevier
Aberrant aggregation of the misfolded presynaptic protein, α-Synuclein (α-Syn) into Lewy
body (LB) and Lewy neuritis (LN) is a major pathological hallmark of Parkinson's disease …

The release of toxic oligomers from α-synuclein fibrils induces dysfunction in neuronal cells

R Cascella, SW Chen, A Bigi, JD Camino… - Nature …, 2021 - nature.com
The self-assembly of α-synuclein (αS) into intraneuronal inclusion bodies is a key
characteristic of Parkinson's disease. To define the nature of the species giving rise to …

Structural basis of membrane disruption and cellular toxicity by α-synuclein oligomers

G Fusco, SW Chen, PTF Williamson, R Cascella… - Science, 2017 - science.org
Oligomeric species populated during the aggregation process of α-synuclein have been
linked to neuronal impairment in Parkinson's disease and related neurodegenerative …

The role of lipids interacting with α-synuclein in the pathogenesis of Parkinson's disease

C Galvagnion - Journal of Parkinson's disease, 2017 - content.iospress.com
Abstract α-synuclein is a small protein abundantly expressed in the brain and mainly located
in synaptic terminals. The conversion of α-synuclein into oligomers and fibrils is the hallmark …

Effects of in vivo conditions on amyloid aggregation

MC Owen, D Gnutt, M Gao, SKTS Wärmländer… - Chemical Society …, 2019 - pubs.rsc.org
One of the grand challenges of biophysical chemistry is to understand the principles that
govern protein misfolding and aggregation, which is a highly complex process that is …

The docking of synaptic vesicles on the presynaptic membrane induced by α-synuclein is modulated by lipid composition

WK Man, B Tahirbegi, MD Vrettas, S Preet… - Nature …, 2021 - nature.com
Abstract α-Synuclein (αS) is a presynaptic disordered protein whose aberrant aggregation is
associated with Parkinson's disease. The functional role of αS is still debated, although it …

Serine-129 phosphorylation of α-synuclein is an activity-dependent trigger for physiologic protein-protein interactions and synaptic function

LA Parra-Rivas, K Madhivanan, BD Aulston, L Wang… - Neuron, 2023 - cell.com
Phosphorylation of α-synuclein at the serine-129 site (α-syn Ser129P) is an established
pathologic hallmark of synucleinopathies and a therapeutic target. In physiologic states, only …

Sequential CRISPR screening reveals partial NatB inhibition as a strategy to mitigate alpha-synuclein levels in human neurons

S Santhosh Kumar, NN Naseri, SR Pather… - Science …, 2024 - science.org
Alpha-synuclein (αSyn) protein levels correlate with the risk and severity of Parkinson's
disease and related neurodegenerative diseases. Lowering αSyn is being actively …

ɑ-Synuclein strains and seeding in Parkinson's disease, incidental Lewy body disease, dementia with Lewy bodies and multiple system atrophy: similarities and …

W Peelaerts, L Bousset, V Baekelandt, R Melki - Cell and tissue research, 2018 - Springer
Several age-related neurodegenerative disorders are characterized by the deposition of
aberrantly folded endogenous proteins. These proteins have prion-like propagation and …